CD44 and breast carcinoma: These observations are in line with reports in breast cancer, where they identified CD44, in particular, its intracellular domain to be critical in influencing the expression of stemness factors and the maintenance of breast CSCs.29 The morphological changes and a decrease in cell migration witnessed in CD44‐silenced cells further validate its role in the EMT process.